|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Deuffic S, Poynard T, Buffat L and
Valleron AJ: Trends in primary liver cancer. Lancet. 351:214–215.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Altekruse SF, Henley SJ, Cucinelli JE and
McGlynn KA: Changing hepatocellular carcinoma incidence and liver
cancer mortality rates in the United States. Am J Gastroenterol.
109:542–553. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Natsuizaka M, Omura T, Akaike T, Kuwata Y,
Yamazaki K, Sato T, Karino Y, Toyota J, Suga T and Asaka M:
Clinical features of hepatocellular carcinoma with extrahepatic
metastases. J Gastroenterol Hepatol. 20:1781–1787. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Roodman GD: Mechanisms of bone metastasis.
N Engl J Med. 350:1655–1664. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
He J, Zeng ZC, Tang ZY, Fan J, Zhou J,
Zeng MS, Wang JH, Sun J, Chen B, Yang P and Pan BS: Clinical
features and prognostic factors in patients with bone metastases
from hepatocellular carcinoma receiving external beam radiotherapy.
Cancer. 115:2710–2720. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bartel DP: MicroRNAs: Target recognition
and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Simonson B and Das S: MicroRNA
therapeutics: The next magic bullet? Mini Rev Med Chem. 6:467–474.
2015. View Article : Google Scholar
|
|
9
|
He L and Hannon GJ: MicroRNAs: Small RNAs
with a big role in gene regulation. Nat Rev Genet. 5:522–531. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Garzon R, Calin GA and Croce CM: MicroRNAs
in cancer. Annu Rev Med. 60:167–179. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Huang S and He X: The role of microRNAs in
liver cancer progression. Br J Cancer. 104:235–240. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Tsai WC, Hsu PW, Lai TC, Chau GY, Lin CW,
Chen CM, Lin CD, Liao YL, Wang JL, Chau YP, et al: MicroRNA-122, a
tumor suppressor microRNA that regulates intrahepatic metastasis of
hepatocellular carcinoma. Hepatology. 49:1571–1582. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhu Q, Wang Z, Hu Y, Li J, Li X, Zhou L
and Huang Y: miR-21 promotes migration and invasion by the
miR-21-PDCD4-AP-1 feedback loop in human hepatocellular carcinoma.
Oncol Rep. 27:1660–1668. 2012.PubMed/NCBI
|
|
14
|
Wang B, Hsu SH, Majumder S, Kutay H, Huang
W, Jacob ST and Ghoshal K: TGFbeta-mediated upregulation of hepatic
miR-181b promotes hepatocarcinogenesis by targeting TIMP3.
Oncogene. 29:1787–1797. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Huang XH, Chen JS, Wang Q, Chen XL, Wen L,
Chen LZ, Bi J, Zhang LJ, Su Q and Zeng WT: miR-338-3p suppresses
invasion of liver cancer cell by targeting smoothened. J Pathol.
225:463–472. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhou Y, Li Y, Ye J, Jiang R, Yan H, Yang
X, Liu Q and Zhang J: MicroRNA-491 is involved in metastasis of
hepatocellular carcinoma by inhibitions of matrix metalloproteinase
and epithelial to mesenchymal transition. Liver Int. 33:1271–1280.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Geng S, Zhang X, Chen J, Liu X, Zhang H,
Xu X, Ma Y, Li B, Zhang Y, Bi Z and Yang C: The tumor suppressor
role of miR-124 in osteosarcoma. PLoS One. 9:e915662014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Li Y, Zhang Z, Liu X, Huang T, He W, Shen
Y, Liu X, Hong K and Cao Q: miR-124 functions as a tumor suppressor
in the endometrial carcinoma cell line HEC-1B partly by suppressing
STAT3. Mol Cell Biochem. 388:219–231. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chu M, Chang Y, Guo Y, Wang N, Cui J and
Gao WQ: Regulation and methylation of tumor suppressor miR-124 by
androgen receptor in prostate cancer cells. PLoS One.
10:e01161972015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Li W, Huang H, Su J, Ji X, Zhang X, Zhang
Z and Wang H: miR-124 Acts as a tumor suppressor in glioblastoma
via the inhibition of signal transducer and activator of
transcription 3. Mol Neurobiol. 54:2555–2561. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Budhu A, Jia HL, Forgues M, Liu CG,
Goldstein D, Lam A, Zanetti KA, Ye QH, Qin LX, Croce CM, et al:
Identification of metastasis-related microRNAs in hepatocellular
carcinoma. Hepatology. 47:897–907. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Xiang ZL, Zeng ZC, Fan J, Tang ZY and Zeng
HY: Expression of connective tissue growth factor and
interleukin-11 in intratumoral tissue is associated with poor
survival after curative resection of hepatocellular carcinoma. Mol
Biol Rep. 39:6001–6006. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Sommer J, Effenberger T, Volpi E, Waetzig
GH, Bernhardt M, Suthaus J, Garbers C, Rose-John S, Floss DM and
Scheller J: Constitutively active mutant gp130 receptor protein
from inflammatory hepatocellular adenoma is inhibited by an
anti-gp130 antibody that specifically neutralizes interleukin 11
signaling. J Biol Chem. 287:13743–13751. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Jia XQ, Cheng HQ, Li H, Zhu Y, Li YH, Feng
ZQ and Zhang JP: Inhibition of connective tissue growth factor
overexpression decreases growth of hepatocellular carcinoma cells
in vitro and in vivo. Chin Med J (Engl). 124:3794–3799.
2011.PubMed/NCBI
|
|
25
|
Gao YB, Xiang ZL, Zhou LY, Wu ZF, Fan J,
Zeng HY and Zeng ZC: Enhanced production of CTGF and IL-11 from
highly metastatic hepatoma cells under hypoxic conditions: An
implication of hepatocellular carcinoma metastasis to bone. J
Cancer Res Clin Oncol. 139:669–679. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Murray MJ, Raby KL, Saini HK, Bailey S,
Wool SV, Tunnacliffe JM, Enright AJ, Nicholson JC and Coleman N:
Solid tumors of childhood display specific serum microRNA profiles.
Cancer Epidemiol Biomarkers Prev. 24:350–360. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zeng B, Li Z, Chen R, Guo N, Zhou J, Zhou
Q, Lin Q, Cheng D, Liao Q, Zheng L and Gong Y: Epigenetic
regulation of miR-124 by hepatitis C virus core protein promotes
migration and invasion of intrahepatic cholangiocarcinoma cells by
targeting SMYD3. FEBS Lett. 586:3271–3278. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Rossi JJ: New hope for a microRNA therapy
for liver cancer. Cell. 137:990–992. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhang Y, Li H, Han J and Zhang Y:
Down-regulation of microRNA-124 is correlated with tumor metastasis
and poor prognosis in patients with lung cancer. Int J Clin Exp
Pathol. 8:1967–1972. 2015.PubMed/NCBI
|
|
30
|
Peng XH, Huang HR, Lu J, Liu X, Zhao FP,
Zhang B, Lin SX, Wang L, Chen HH, Xu X, et al: miR-124 suppresses
tumor growth and metastasis by targeting Foxq1 in nasopharyngeal
carcinoma. Mol Cancer. 13:1862014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kessenbrock K, Plaks V and Werb Z: Matrix
metalloproteinases: Regulators of the tumor microenvironment. Cell.
141:52–67. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Musso O, Théret N, Campion JP, Turlin B,
Milani S, Grappone C and Clément B: In situ detection of matrix
metalloproteinase-2 (MMP2) and the metalloproteinase inhibitor
TIMP2 transcripts in human primary hepatocellular carcinoma and in
liver metastasis. J Hepatol. 26:593–605. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Jiang F, Chen L, Yang YC, Wang XM, Wang
RY, Li L, Wen W, Chang YX, Chen CY, Tang J, et al: CYP3A5 functions
as a tumor suppressor in hepatocellular carcinoma by regulating
mTORC2/Akt signaling. Cancer Res. 75:1470–1481. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Yuan Z, Liu S, Yao J, Zeng Q, Tan S and
Liu Z: Expression of Bcl-2 genes in channel catfish after bacterial
infection and hypoxia stress. Dev Comp Immunol. 65:79–90. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Lasithiotaki I, Antoniou KM, Derdas SP,
Sarchianaki E, Symvoulakis EK, Psaraki A, Spandidos DA,
Stathopoulos EN, Siafakas NM and Sourvinos G: The presence of
Merkel cell polyomavirus is associated with deregulated expression
of BRAF and Bcl-2 genes in non-small cell lung cancer. Int J
Cancer. 133:604–611. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Cohen GM: Caspases: The executioners of
apoptosis. Biochem J. 326:1–16. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Korsmeyer SJ: BCL-2 gene family and the
regulation of programmed cell death. Cancer Res. 59 7
Suppl:S1693–S1700. 1999.
|
|
38
|
Ren C, Chen Y, Han C, Fu D and Chen H:
Plasma interleukin-11 (IL-11) levels have diagnostic and prognostic
roles in patients with pancreatic cancer. Tumour Biol.
35:11467–11472. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Zhou C, Ji J, Cai Q, Shi M, Chen X, Yu Y,
Zhu Z and Zhang J: MTA2 enhances colony formation and tumor growth
of gastric cancer cells through IL-11. BMC Cancer. 15:343–352.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Pan D, Xu L, Liu H, Zhang W, Liu W, Liu Y,
Fu Q and Xu J: High expression of interleukin-11 is an independent
indicator of poor prognosis in clear-cell renal cell carcinoma.
Cancer Sci. 106:592–597. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Xiang ZL, Zeng ZC, Tang ZY, Fan J, He J,
Zeng HY and Zhu XD: Potential prognostic biomarkers for bone
metastasis from hepatocellular carcinoma. Oncologist. 16:1028–1039.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Wang A, Duan G, Zhao C, Gao Y, Liu X, Wang
Z, Li W, Wang K and Wang W: Reduced RKIP expression levels are
associated with frequent non-small cell lung cancermetastasis and
STAT3 phosphorylation and activation. Oncol Lett. 13:3039–3045.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Yang S, Luo C, Gu Q, Xu Q, Wang G, Sun H,
Qian Z, Tan Y, Qin Y, Shen Y, et al: Activating JAK1 mutation may
predict the sensitivity of JAK-STAT inhibition in hepatocellular
carcinoma. Oncotarget. 7:5461–5469. 2016.PubMed/NCBI
|
|
44
|
Liu S, Hu C, Wang Y, Shi G, Li Y and Wu H:
miR-124 inhibits proliferation and invasion of human retinoblastoma
cells by targeting STAT3. Oncol Rep. 36:2398–2404. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Calvisi DF, Ladu S, Gorden A, Farina M,
Conner EA, Lee JS, Factor VM and Thorgeirsson SS: Ubiquitous
activation of Ras and Jak/Stat pathways in human HCC.
Gastroenterology. 130:1117–1128. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Wu J, Wang Y, Xu X, Cao H, Sahengbieke S,
Sheng H, Huang Q and Lai M: Transcriptional activation of FN1 and
IL11 by HMGA2 promotes the malignant behavior of colorectal cancer.
Carcinogenesis. 37:511–521. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Yuan JH, Yang F, Wang F, Ma JZ, Guo YJ,
Tao QF, Liu F, Pan W, Wang TT, Zhou CC, et al: A long noncoding RNA
activated by TGF-β promotes the invasion-metastasis cascade in
hepatocellular carcinoma. Cancer Cell. 25:666–681. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Lamarca A, Mendiola M, Bernal E, Heredia
V, Díaz E, Miguel M, Pastrian LG, Burgos E, Feliu J and Barriuso J:
Tumoural expression of connective tissue growth factor (CTGF)
impacts on survival in patients diagnosed with hepatocellular
carcinoma (HCC). Curr Cancer Drug Targets. 15:435–444. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Cai QQ, Dong YW, Wang R, Qi B, Guo JX, Pan
J, Liu YY, Zhang CY and Wu XZ: miR-124 inhibits the migration and
invasion of human hepatocellular carcinoma cells by suppressing
integrin αV expression. Sci Rep. 7:407332017. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Zheng F, Liao YJ, Cai MY, Liu YH, Liu TH,
Chen SP, Bian XW, Guan XY, Lin MC, Zeng YX, et al: The putative
tumour suppressor microRNA-124 modulates hepatocellular carcinoma
cell aggressiveness by repressing ROCK2 and EZH2. Gut. 61:278–289.
2012. View Article : Google Scholar : PubMed/NCBI
|
